Verily, Google's Life Sciences Arm, Plans to Raise Funds and Outline AI Strategy by 2025 Amid Potential Google Breakup

Verily, the life sciences subsidiary of Google’s parent company Alphabet, is reportedly planning to raise funds from outside investors and outline its artificial intelligence (AI) strategy by 2025. This move comes as Alphabet faces increasing pressure from investors to break up its various businesses, including Google. According to sources familiar with the matter, Verily aims to raise money to fuel its growth and potentially spin off from Alphabet. The company is exploring ways to leverage AI in healthcare, such as using machine learning for drug discovery and medical imaging analysis. Verily’s fundraising efforts and AI strategy could position it as a standalone entity if Alphabet decides to restructure or break up its businesses. The potential separation from Google would allow Verily to operate more independently and attract investment from healthcare and technology companies interested in its AI capabilities.

Source: https://www.businessinsider.com/verily-fundraise-2025-ai-strategy-google-breakup-2024-12